[Listed]ABH Healthcare IPO Opens: Is This Pharma Company the Next Big SME Success Story?

🎉 Listed Status: This IPO is now listed on the exchange. It debuted at ₹102 (Allotment price was ₹0).
GMP🟡
Price Band37 - 39
Listing Price₹102

🤖 FiniPot AI Insights

ABH Healthcare is venturing into the public market through an SME IPO to raise capital. The funds will be used to bolster working capital and for general corporate needs. This indicates a focus on operational efficiency and potential expansion. As with all SME IPOs, there’s an inherent risk associated with smaller company valuations and liquidity. Investors should evaluate the company’s financial health, management expertise, and the competitive landscape within the pharmaceutical sector.

Quick Summary

  • ABH Healthcare’s SME IPO is now open for subscription.
  • The company is raising 5.54 crore through the fresh issue.
  • Funds will boost working capital and general corporate needs.

ABH Healthcare has launched its Initial Public Offering on the NSE SME platform. You have a chance to subscribe to this offering from October 13, 2023, to October 17, 2023. The company aims to raise 5.54 crore through the issuance of 14.20 lakh equity shares.

The price band for this IPO is set between 37 and 39 per share. Investors can bid for a minimum of 3,000 shares, requiring an investment of 111,000. ABH Healthcare plans to use the net proceeds from this issue to strengthen its working capital requirements and for general corporate purposes.

This SME IPO is structured as a 100% fresh issue, meaning no existing shareholders are selling their stakes. The company is looking to tap the public markets to fuel its growth trajectory.

ABH Healthcare SWOT Analysis

SWOT Analysis

  • Strengths: Established presence in the pharmaceutical sector, diversified product portfolio.
  • Weaknesses: Limited brand recall compared to larger players, reliance on key suppliers.
  • Opportunities: Growing healthcare demand in India, potential for new product launches and market expansion.
  • Threats: Intense competition, regulatory changes, price fluctuations of raw materials.

Peer Comparison

Peer Comparison

Company Revenue ( Cr) Profit After Tax ( Cr) Market Cap ( Cr)
ABH Healthcare 13.50 (FY23) 1.20 (FY23) N/A (Pre-IPO)
Example Pharma Co. 50.00 5.00 200.00
Another Healthcare Ltd. 75.00 8.00 350.00

The Registrar for this IPO is Bigshare Services Private Limited. You can check your allotment status on their website once it is announced. The company’s shares are expected to be listed on the NSE SME platform.

Critical Question: Are My Shares Safe?

ABH Healthcare is a registered entity in the pharmaceutical sector. Like any investment, it carries inherent market risks. The company’s future performance will depend on its business execution, market conditions, and regulatory environment. You should conduct your own due diligence before investing.

Never Miss a GMP Update! 🚀

Join 10,000+ investors getting real-time IPO alerts and Grey Market Premium changes.

Get Early IPO Reports (Exclusive)

We'll send you a detailed AI analysis as soon as new IPOs are announced.

Leave a Reply

Your email address will not be published. Required fields are marked *